Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

Clinical trial NCT04945148 · RECRUITING

Trial details

NCT number: NCT04945148
Sponsor: Hopital Foch
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma, IDH-wildtype

Start date: 2024-05-10
Primary completion: 2028-05-01
Enrollment: 640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.